Effect of Churnaratnam and Swaguptadi Churna in Oligospermia.

A COMPARATIVE CLINICAL STUDY OF CHURNARATNAM AND SWAGUPTADI CHURNA IN THE MANAGEMENT OF KSHEENA SHUKRA W.S.R. TO OLIGOZOOSPERMIA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014340

Enrollment

Registered

2018-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- fullfilled inclusion criteria

Interventions

Intervention1: Churnaratnam : Dosage form- churna Dose- 2gm, Twice A Day Mode of Administration : Oral Time of Administration : Morning and Evening Anupana- A Cup Of Warm Milk Duration- 60

Eligibility

Inclusion criteria

Inclusion criteria: Sperm count Patient with clinical presentation of Ksheenashukra ( Oligozoospermia ) .i.e. Daurbalya, Klaibya, Shukra Avisarga, Pandu etc .

Exclusion criteria

Exclusion criteria: Age below 21 and above 50 years. Sperm count >15 million/ml Patient of azoospermia and aspermia Patients of various diseases like varicocele, accessory sex gland infection, sexually transmitted diseases, severe systemic diseases & DM etc. Genetic disorders like Klinfelterâ??s syndrome. Taking treatment for major psychiatric problem History of previous medications and trauma leading to oligozoospermia.

Design outcomes

Primary

Measure	Time frame
60 days intervention 4 weeks followupTimepoint: 60 days intervention 4 weeks followup	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactAlankruta Dave

IPGT and RA Jamnagar

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026